SCHEMBL18574253

SCHEMBL18574253

Cc1cn([C@@H]2O[C@@]3(CO)CO[C@H]2C3I)c(=O)nc1N

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.32
ADORA3 P0DMS8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5992610 0.89 ADORA3 (0.37) ALBADORA3
SCHEMBL4313991 0.89 ADORA3 (0.37) ALBADORA3
SCHEMBL4313984 0.89 ADORA3 (0.37) ALBADORA3
SCHEMBL14929428 0.89 ADORA3 (0.37) ALBADORA3
SCHEMBL14946290 0.88 ALB (0.32) ALB
SCHEMBL23906488 0.87 ALB (0.34) ALB
SCHEMBL20739006 0.86 ALB (0.31) ALB
SCHEMBL22112114 0.85 ALB (0.31) ALB
SCHEMBL22666373 0.85 ALB (0.31) ALB
SCHEMBL26044331 0.85 ALB (0.31) ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170056528-A1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF MODERNATX, INC. 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170056528-A1 MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF ADAR, NT5C3B, NSUN2 ALB 3909/4885ADORA3 103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.